Atlas Trials

Clinical Trial for Measles - Rubella Combined Vaccine (MRVAC) Produced by POLYVAC (Phase III)

Clinical trial NCT03713359 · COMPLETED

Trial details

NCT number
NCT03713359
Sponsor
Center for Research and Production of Vaccines and Biologicals, Vietnam
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Signs and Symptoms
Start date
2016-04-01
Primary completion
2016-07-01
Enrollment
756

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.